Comparison of 125I-angiotensin III and 125I-angiotensin II binding to rat brain membranes.
The binding of 125I-angiotensin III (125I-ANG III) to rat brain membranes was examined and compared with that of 125I-angiotensin II (125I-ANG II). Degradation of each ligand, as monitored by HPLC, was effectively inhibited using fragments of ANG III and ANG II known to have little affinity for angiotensin binding sites. Three classes of 125I-ANG III-binding sites were observed based on affinity (KD = 0.13, 1.83, and 10.16 nM) and capacity (Bmax = 1.30, 18.41, and 67.2 fmol/mg protein, respectively). Two classes of 125I-ANG II-binding sites of high affinity (KD = 0.11 and 1.76 nM) and low capacity (Bmax = 1.03 and 18.86 fmol/mg protein, respectively) were also identified. Cross-displacement studies confirmed that the two highest-affinity 125I-ANG III-binding sites and the 125I-ANG II-binding sites were the same. On the other hand, the binding of 125I-ANG III to the low-affinity 125I-ANG III-binding site could not be inhibited with ANG II. These data imply that previously measured differences in the biological potency of cerebroventricularly applied ANG III and ANG II probably do not result from differential binding of these peptides to central angiotensin receptors.
Abhold
R H
RH
Dept. Vet. Comp. Anat. Pharmacol. Physiol., Washington State University, Pullman 99164-6520.
Hanesworth
J M
JM
Harding
J W
JW
D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000378:metabolism*; D000805:Angiotensin III / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D001921:Brain / Q000378:metabolism*; D007457:Iodine Radioisotopes; D008297:Male; D008566:Membranes / Q000378:metabolism; D010446:Peptide Fragments / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
D007457:Iodine Radioisotopes; D010446:Peptide Fragments; D000804:Angiotensin II; D000805:Angiotensin III